Frequently Asked Questions
Alzheimer’s Therapeutic market also suffered from COVID 19 pandemic. Some research studies for Alzheimer’s disease were put on hold during the pandemic outbreak out of concern for contamination.
North America accounted for the highest share in the global Alzheimer’s Therapeutic market in terms of value as well as volume.
The increased incidence and prevalence of Alzheimer’s disease, expanding public health awareness about the condition, and the development of breakthrough technologies and treatments to extend life expectancy are all driving the market.
The cholinesterase inhibitors segment accounts for the biggest revenue share of the Global Alzheimer’s Therapeutics market in 2021 and is likely to dominate the market over the forecast period as they are often used by healthcare professionals to treat symptoms linked with memory, thinking, language, judgment, and other thought processes.
Online Pharmacies had a major share in the global market in 2021 and are projected to continue their dominance over the forecast period.